⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

SUN PHARMACEUTICAL INDUSTRIES INC: Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick

DrugsSource: FDA (drug) · Date: 2026-07-08

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Sun Pharmaceutical Industries

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
SUN PHARMACEUTICAL INDUSTRIES INC
Product
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
Reason / hazard
Failed Impurities/Degradation Specifications
Classification
Class III
Status
Ongoing
Distribution / sold at
U.S. Nationwide
Recall initiated
2026-06-01
Code info
Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026
Product quantity
9,048 bottles
Voluntary mandated
Voluntary: Firm initiated
City
Princeton
State
NJ
Country
United States
Event id
99110
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.